The first major wave of MoCRA cosmetic facility registration renewals is now underway. Many manufacturers and processors completed their initial mandatory registrations in 2024, which means their two-year renewal dates fall in 2026. The deadline is easy to misunderstand because cosmetic registration does not follow the universal October 1 through December 31 window used for food facility renewals or annual drug establishment registration. Under section 607(a)(2) of the Federal Food, Drug, and Cosmetic Act, a covered cosmetic facility renews every two years from its own initial registration date. A facility first registered on February 20, 2024 would therefore have a renewal date of February 20, 2026. Another facility first registered in June has a different deadline. Each record must be managed on its own calendar.
Cosmetics Direct now shows registration status and renewal date
In February 2026, FDA updated Cosmetics Direct and its supporting materials for biennial renewals. The cosmetic product facility registration homepage now displays REGISTRATION STATUS and RENEWAL DATE fields. FDA also sends automated reminders before the renewal date to contacts associated with the registration, which may include the facility contact, FDA Direct account contact, US Agent, additional contact, and paper submitter. These reminders are useful but should not be the company's only control. Contact details change, messages are filtered, and responsibility can move between a brand, contract manufacturer, consultant, and US Agent. The authoritative internal control should be a regulatory calendar tied to the FDA record and reviewed well before the displayed renewal date.
Who is responsible for facility registration and renewal
Every person that owns or operates a facility engaged in manufacturing or processing a cosmetic product for distribution in the United States must register each covered facility unless an exemption applies. The obligation is attached to the physical manufacturing or processing facility, not simply to the brand. For a contract manufacturer, the registration may be submitted by the contract manufacturer or by a Responsible Person whose products are manufactured or processed there. That flexibility does not remove the need for clear ownership. The parties should agree who controls the FDA submission, who holds the submission records, who receives reminders, and who will renew or amend the registration. A brand should not assume its contract manufacturer renewed merely because the FEI remains visible in an old document.
Foreign facilities must keep the US Agent relationship active
A foreign cosmetic facility registration includes a US Agent located in the United States. The US Agent is a communication link between FDA and the foreign facility, and the agent's information forms part of the registration record. Before renewal, the facility should confirm that the agent is still appointed, that the contact information is current, and that the agent is prepared to respond to FDA communications. If the relationship ended or the information changed, the record should not be renewed as though nothing happened. The facility should coordinate the change and file the correct renewal or amendment. Allowing reminders or FDA questions to go to an inactive agent can turn a manageable filing issue into an avoidable market-access problem.
The FEI remains the required facility identifier
FDA intends to use the FDA Establishment Identifier, or FEI, as the required facility registration number for cosmetic facilities. The owner or operator should obtain or confirm the FEI before preparing the facility submission and should make sure that the legal name and physical address associated with the facility are accurate. An FEI identifies the establishment; it is not proof that a MoCRA registration is currently active, and it is not a product approval number. Companies managing multiple factories must keep each physical site separate. Using the FEI for a headquarters, trading company, or neighboring plant in place of the actual manufacturer creates an identity mismatch that can affect the registration and product listings connected to it.
Choose the correct renewal type
Cosmetics Direct provides two biennial renewal submission options using the latest version of the Structured Product Labeling record. COSMETIC PRODUCT FACILITY REGISTRATION - BIENNIAL RENEWAL is used when the registration is being renewed with changes. COSMETIC PRODUCT FACILITY REGISTRATION - ABBREVIATED RENEWAL is available when there have been no updates to the registration since the most recent facility registration submission. Selecting the abbreviated route is a certification that no changes have been made. It should follow an actual comparison of the current legal name, address, parent company information, facility contacts, US Agent, product categories, and other required fields against the latest accepted record. Convenience is not a valid reason to use the abbreviated option when the facts changed.
Do not wait for renewal to report changes
Biennial renewal is not a substitute for amendment. A person required to register must update the facility registration within 60 days of a change to required registration information. That includes changes that result in cancellation. If a facility moved, changed its legal name, replaced its US Agent, changed ownership details, or stopped manufacturing cosmetic products for US distribution, the company should evaluate the 60-day update obligation when the change occurs. Waiting for the two-year renewal date can leave FDA with an inaccurate record for months. A strong compliance process treats event-driven amendments and calendar-driven renewals as separate controls.
Facility renewal and product listing are different obligations
MoCRA created both facility registration and cosmetic product listing, but the duties belong to different actors and run on different schedules. The facility owner or operator manages the facility registration. The Responsible Person—the manufacturer, packer, or distributor whose name appears on the cosmetic label—must list each marketed cosmetic product and provide updates annually. Product listing information includes the facilities where the product is manufactured or processed and the product's ingredients. Renewing a factory does not renew every product listing, and updating product listings does not renew the facility. A complete portfolio review must reconcile both sides so that active products point to active, accurate facility records.
Annual product listing updates need a controlled portfolio
The Responsible Person must provide updates to each cosmetic product listing annually, including an update when a product is discontinued. FDA provides an abbreviated process for a listing that has not changed since the previous submission. For an international brand, the difficult part is rarely clicking the renewal option. It is controlling the underlying portfolio: US product names, formulations, ingredient lists, Responsible Person label identities, manufacturing facilities, discontinuations, and relaunches. A formula change, new contract manufacturer, acquisition, private-label variant, or discontinued shade can affect the record. The annual review should compare regulatory data to the products actually marketed in the United States, not to a global master list that includes products never sold there.
Small-business exemptions are limited
MoCRA exempts certain qualifying small businesses from facility registration and product listing, using a statutory sales threshold that is adjusted for inflation. The exemption is not available for facilities or Responsible Persons associated with specified higher-risk product types, including products that regularly contact the mucus membrane of the eye, injected products, products intended for internal use, and products intended to alter appearance for more than 24 hours when consumer removal is not ordinarily part of use. Drug-device overlap can also change which registration and listing framework applies. A company should document the financial calculation, product analysis, affiliates considered, and the date of the conclusion rather than checking a small-business box based on headcount or intuition.
Registration is not FDA approval and there is no filing fee
FDA states that cosmetic product facility registration and product listing are neither an approval program nor a promotional tool, and FDA does not issue certificates for these submissions. There is also no FDA fee to submit a MoCRA facility registration or product listing. Service providers may charge for regulatory work, US Agent support, data preparation, or submission management, but that should not be described as an FDA registration fee. Labels, websites, distributor presentations, and marketplace listings should never imply that a cosmetic is FDA approved because a facility was registered or a product was listed. The records show compliance with filing duties; they do not establish that FDA reviewed and endorsed the product.
What happens when the renewal is missed
Failure to register or submit required listing information in accordance with section 607 is a prohibited act under the FD&C Act. FDA also has authority to suspend a facility registration when the statutory serious-health-risk conditions are met. A missed renewal does not merely create an administrative housekeeping problem: it creates uncertainty about whether the facility's registration is active and whether products connected to it can continue moving through a compliant US supply chain. Importers, marketplaces, retailers, and Responsible Persons increasingly ask manufacturers for current registration information. The safest response is prevention—confirm the renewal date, prepare the correct submission, retain the acceptance record, and then reconcile the related product listings.
The 2026 renewal checklist
- Open the current Cosmetics Direct facility record and confirm the REGISTRATION STATUS and RENEWAL DATE shown by FDA.
- Verify the FEI, legal facility name, physical address, owner or operator, parent company information, contacts, US Agent, and cosmetic product categories.
- Compare the current facts with the latest accepted submission and choose full biennial renewal when changes exist or abbreviated renewal only when no changes exist.
- Resolve any overdue amendments instead of carrying inaccurate information into another renewal cycle.
- Save the submitted SPL, FDA acknowledgment, date, account owner, and supporting review record in the facility's compliance file.
- Separately reconcile every US cosmetic product listing and complete the required annual updates or discontinuations.
How FDABridge manages MoCRA renewals
FDABridge supports foreign cosmetic manufacturers and Responsible Persons with FEI confirmation, US Agent coordination, MoCRA facility registration and biennial renewal, cosmetic product listing, annual portfolio updates, label review, and ongoing adverse-event compliance. We review the record before selecting a renewal type and keep facility and product obligations separate so one completed filing does not hide another missed deadline. FDA's current renewal information is available at https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products, and the detailed registration and listing guidance is available at https://www.fda.gov/media/170732/download. To review a 2026 renewal or product portfolio, visit https://fdabridge.com/contact.
Need help with MoCRA filings?
See our cosmetics services for facility registration, product listing, and label review support.